Are Wegovy Pens Adjustable — and Who Controls the Dose?

The decision that matters: which pen your prescriber chooses

The framing of this question, are Wegovy pens adjustable?, often reflects a broader concern: can I control my dose if things feel too strong, or push faster if progress stalls? The honest answer is that the pen itself gives you no control at all. What you inject is fixed the moment the pen is manufactured. The control sits entirely with your prescriber, which is the point.

The licensed dose pathway for semaglutide (Wegovy) starts at 0.25 mg weekly. That first pen is not a therapeutic dose in the sense of producing meaningful weight loss immediately; its purpose is to let your digestive system adjust, reducing the nausea and gastrointestinal discomfort that can come with starting a GLP-1 medicine. Progression through 0.5 mg, 1.0 mg, and 1.7 mg follows at roughly four-week intervals, reaching the standard 2.4 mg maintenance dose. The NHS semaglutide patient page sets out this schedule as reference, though your prescriber determines your actual pace based on how you're tolerating each stage.

If the jump to the next strength causes side effects you find unacceptable, your prescriber can hold you at the current pen for longer. There is no mechanism to split a pen's dose across two weeks or top up partway through one. The pen fires once per week, delivers its fixed amount, and that's the structure. It is a simpler system than it sounds once you're in it, and for most people the schedule becomes routine fairly quickly.

The newer 7.2 mg pen and what makes it different

In April 2026, the MHRA approved a dedicated single-dose 7.2 mg Wegovy pen, the first higher-dose option beyond 2.4 mg. This pen was designed with a built-in covered needle and an auto-dosing mechanism that locks after use, so there is no injection dial or plunger to manage. It is, if anything, even more fixed than the earlier pens. The MHRA's announcement on GOV.UK confirms the 7.2 mg pen is licensed for adults with a BMI of 30 or above, it is not indicated for the cardiovascular or MASH uses of semaglutide, and does not replace the standard titration pathway; you still begin at 0.25 mg and work upward with your prescriber.

Trials of the 7.2 mg dose reported average weight loss of around 20.7% over 72 weeks, which narrows the gap with tirzepatide's headline figures. For context on how these medicines compare at their highest doses, the Wegovy treatment overview on this site lays out the evidence side by side. Specific dose and pen availability is always confirmed during a clinical consultation, not before.

One practical note worth knowing: the needle on the older pens can be changed before each injection. Replacing the needle every time is standard practice, and replacement needles are available separately if you need them. This is about hygiene and comfort, not dose adjustment, the medication volume inside the pen does not change.

What this means if you're deciding how to manage your treatment

If you're weighing up whether the fixed-dose structure suits you, it helps to think of it this way: the pen cannot be miscalibrated by the patient, which removes one category of error entirely. You inject what your prescriber prescribed. What you can and should do is communicate clearly with your clinical team when something isn't right, side effects that feel unmanageable, a plateau in progress, or uncertainty about your next step.

At nume, a clinician personally reviews your consultation rather than passing it through an automated filter. If you order before 12pm on a weekday (roughly the time the school run is wrapping up) a GPhC-registered Independent Prescriber reads your answers the same day, and treatment that is clinically approved is dispatched that afternoon via DPD for next-working-day delivery. Aftercare runs seven days a week. The question of which pen strength you need next is exactly the kind of thing our prescribers handle as part of an ongoing clinical relationship, not a one-time form.

For a broader look at the injection process itself, the Wegovy injectable pen guide covers how to prepare and administer each dose, and the travel guidance page addresses storage and carrying your pens safely when you're away from home. If you're still working out which treatment option fits your situation, the weight loss treatments overview compares the available licensed options without any pressure to pick one immediately.

Practical FAQs about pen adjustment that come up most often

Prescribers at nume hear a version of the same question regularly: can I just use a lower dose if the 1.0 mg feels too strong this week? The answer is no, once a pen is prescribed at a given strength, that is the dose it delivers. You cannot use half a pen one week and the other half the next; if you want a full explanation of how Wegovy pens are structured, including what each pen contains and how the four-week supply works, that page sets it out clearly. Splitting or reusing a pen between weeks introduces real risk of infection and potential dose error, and the SmPC is explicit that pens should not be shared between patients under any circumstances.

Questions also come up about whether travel, heat, or storage problems can affect the dose delivered. They can affect the medicine's stability, which is a different issue, if a pen has been outside the recommended cold chain for longer than the Patient Information Leaflet allows, it should not be used regardless of how it looks. The dose mechanism itself is unaffected by temperature, but a degraded medicine may not perform as expected. The leaflet inside your pack is the definitive source on storage windows; our FAQs page covers the most common storage and handling questions. For cost context across the different dose stages, this page on Wegovy pricing in the UK sets out what private treatment typically costs at each strength and what should be included in a legitimate price.

If you have questions about your specific situation or want a clinical view on which strength is right for you, speak to our prescribers through a free consultation, and if you'd like background reading before that conversation, the injectable semaglutide overview explains how the medicine works, what the evidence shows, and what to expect from treatment.